A startup that played a crucial role in developing Oxford University’s coronavirus vaccine is hatching plans to go public — but the centuries-old school may be standing in the way, a new report says. The startup, Vaccitech, was founded in 2016 by two Oxford scientists who created the immunization technology powering the COVID-19 shot that...
